Showing results (1891-1900 of 1,909) with videos related to
Sort By:
Pageof 191
Science Advances|February 4, 2021
A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and bloodDianna L Ng, Andrea C Granados, Yale A Santos, et al.The Lancet. Oncology|July 1, 2026
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trialHerui Yao, Qingyuan Zhang, Huiping Li, et al.Circulation|February 24, 2025
Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized TrialGregory M Marcus, Roderick Tung, Edward P Gerstenfeld, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 25, 2005
The design and application of DNA chips for early detection of SARS-CoV from clinical samplesYi-Ming Zhou, Ren-quan Yang, Sheng-ce Tao, et al.The Lancet. Oncology|November 27, 2025
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trialHuiping Li, Jieqiong Liu, Quchang Ouyang, et al.American Journal of Human Genetics|June 7, 2011
Genetic variants at 13q12.12 are associated with high myopia in the Han Chinese populationYi Shi, Jia Qu, Dingding Zhang, et al.Environmental Science and Ecotechnology|November 15, 2023
The 2022 report of synergetic roadmap on carbon neutrality and clean air for China: Accelerating transition in key sectorsYu Lei, Zhicong Yin, Xi Lu, et al.Environmental Science and Ecotechnology|December 24, 2024
The 2023 report of the synergetic roadmap on carbon neutrality and clean air for China: Carbon reduction, pollution mitigation, greening, and growthJicheng Gong, Zhicong Yin, Yu Lei, et al.Cell|May 15, 2021
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variantXianding Deng, Miguel A Garcia-Knight, Mir M Khalid, et al.Nature Medicine|January 8, 2024
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trialZefei Jiang, Quchang Ouyang, Tao Sun, et al.Pageof 191